5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I

Author(s): Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, et al.

Abstract

In humans, the precursor to all steroid hormones, pregnenolone, is synthesized from cholesterol by an enzyme complex comprising adrenodoxin reductase (AdR), adrenodoxin (Adx), and a cytochrome P450 (P450scc or CYP11A1). This complex not only plays a key role in steroidogenesis, but also has long been a model to study electron transfer, multistep catalysis, and C–C bond cleavage performed by monooxygenases. Detailed mechanistic understanding of these processes has been hindered by a lack of structural information. Here we present the crystal structure of the complex of human Adx and CYP11A1—the first of a complex between a eukaryotic CYP and its redox partner. The structures with substrate and a series of reaction intermediates allow us to define the mechanism underlying sequential hydroxylations of the cholesterol and suggest the mechanism of C–C bond cleavage. In the complex the [2Fe-2S] cluster of Adx is positioned 17.4 â„« away from the heme iron of CYP11A1. This structure suggests that after an initial protein–protein association driven by electrostatic forces, the complex adopts an optimized geometry between the redox centers. Conservation of the interaction interface suggests that this mechanism is common for all mitochondrial P450s.

Similar Articles

Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis

Author(s): Chin KL, Anis FZ, Sarmiento ME, Norazmi MN, Acosta A, et al.

Role of Type I and II Interferons in Colorectal Cancer and Melanoma

Author(s): Di Franco S, Turdo A, Todaro M, Stassi G

Innate immune response induced by gene delivery vectors

Author(s): Sakurai H, Kawabata K, Sakurai F, Nakagawa S, Mizuguchi H, et al.

Analysis of Pro-inflammatory Cytokine and Type II Interferon Induction by Nanoparticles

Author(s): Potter TM, Neun BW, Rodriguez JC, Ilinskaya AN, Dobrovolskaia MA, et al.

More than 70 years of pyrogen detection: Current state and future perspectives

Author(s): Fennrich S, Hennig U, Toliashvili L, Schlensak C, Wendel HP, et al.

Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test

Author(s): Hasiwa N, Daneshian M, Bruegger P, Fennrich S, Hochadel A, et al.

International validation of novel pyrogen tests based on human monocytoid cells

Author(s): Hoffmann S, Peterbauer A, Schindler S, Fennrich S, Poole S, et al.

Nucleic acids as therapeutic agents

Author(s): Alvarez-Salas LM

Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents

Author(s): Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, et al.

Aptamers as therapeutics

Author(s): Keefe AD, Pai S, Ellington A